Human embryonic stem cells show low-grade microsatellite instability

Molecular Human Reproduction

Volumn 20, Issue 10, 2014, Pages 981-989

  Nguyen, Ha Thi ^a   Markouli, Christina ^a   Geens, Mieke ^a   Barbé, Lise ^a   Sermon, Karen ^a   Spits, Claudia ^a  

^a FACULTY OF MEDICINE AND PHARMACY   (Belgium)

Author keywords

Human embryonic stem cells; Microsatellite instability; Mismatch repair system

Indexed keywords

PROTEIN MLH1; PROTEIN MSH2;

ALLELE; ARTICLE; CANCER CELL; CHROMOSOME 15; CHROMOSOME 18; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; DNA REPLICATION; EMBRYONIC STEM CELL; GENE EXPRESSION; GENE FREQUENCY; GENOMIC INSTABILITY; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MULTIPLEX POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; UNIPARENTAL DISOMY; CELL LINE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; MUTATION RATE;

CELL LINE; COMPARATIVE GENOMIC HYBRIDIZATION; DNA MISMATCH REPAIR; DNA REPLICATION; EMBRYONIC STEM CELLS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MICROSATELLITE INSTABILITY; MUTATION RATE;

EID: 84917698356     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gau059     Document Type: Article

References (47)

1. Aaltonen LA, Peltomäki P, Leach FS, Sistonen P, Pylkkänen L, Mecklin JP, Järvinen H, Powell SM, Jen J, Hamilton SR. Clues to the pathogenesis of familial colorectal cancer. Science1993;260:812-816.
2. Abdel-Rahman W, Peltomäki P. Molecular basis and diagnostics of hereditary colorectal cancers. Ann Med 2004;36:379-388.
3. Amps K, Andrews PW, Anyfantis G, Armstrong L, Avery S, Baharvand H, Baker J, Baker D, Munoz MB, Beil S et al. Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol 2011;29: 1132-1144.
4. Avery S, Hirst AJ, Baker D, Lim CY, Alagaratnam S, Skotheim RI, Lothe RA, Pera MF, Colman A, Robson P et al. BCL-XL mediates the strong selective advantage of a 20q11.21 amplification commonly found in human embryonic stem cell cultures. Stem Cell Reports 2013;1:1-8.
5. Baker D, Harrison NJ, Maltby E, Smith K, Moore HD, Shaw PJ, Heath PR, Holden H, Andrews PW. Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nat Biotechnol 2007;25:207-215.
6. Beqqali A, van Eldik W, Mummery C, Passier R. Human stem cells as a model for cardiac differentiation and disease. Cell Mol Life Sci 2009;66:800-813.
7. Beroukhim R, Mermel CH, Porter D, Wei G, Donovan J, Barretina J, Boehm JS, Urashima M, Henry KTM, Pinchback RM et al. The landscape of somatic copy-number alteration across human cancers. Nature 2010; 463:899-905.
8. Biancotti J-C, Narwani K, Buehler N, Mandefro B, Golan-Lev T, Yanuka O, Clark A, Hill D, Benvenisty N, Lavon N. Human embryonic stem cells as models for aneuploid chromosomal syndromes. Stem Cells 2010; 28:1530-1540.
9. Boland CR, Goel A. Somatic evolution of cancer cells. Semin Cancer Biol 2005; 15:436-450.
10. Boland CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology 2011;138:2073s-2087.
11. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248-5257.
12. Buysse K, Delle Chiaie B, Coster R, Loeys B, Paepe A, Mortier G, Speleman F, Menten B. Challenges for CNV interpretation in clinical molecular karyotyping: lessons learned from a 1001 sample experience. Eur J Med Genet 2009;52:398-403.
13. Dekel-Naftali M, Aviram-Goldring A, Litmanovitch T, Shamash J, Reznik-Wolf H, Laevsky I, Amit M, Itskovitz-Eldor J, Yung Y, Hourvitz A et al. Screening of human pluripotent stem cells using CGH and FISH reveals low-grade mosaic aneuploidy and a recurrent amplification of chromosome 1q. Eur J Hum Genet 2012;20:1248-1255.
14. Findeisen P, Kloor M, Merx S, Sutter C, Woerner SM, Dostmann N, Benner A, Dondog B, Pawlita M, Dippold W et al. T25 repeat in the 3' untranslated region of the CASP2 gene: a sensitive and specific marker for microsatellite instability in colorectal cancer. Cancer Res 2005; 65:8072-8078.
15. Fraga AM, Souza de Araújo ÉS, Stabellini R, Vergani N, Pereira LV.Asurvey of parameters involved in the establishment of newlines of human embryonic stem cells. Stem Cell Rev 2011;7:775-781.
16. Friedrich Ben-Nun I, Benvenisty N. Human embryonic stem cells as a cellular model for human disorders. Mol Cell Endocrinol 2006;252:154-159.
17. Geens M, Mateizel I, Sermon K, Rycke M, Spits C, Cauffman G, Devroey P, Tournaye H, Liebaers I, Velde H. Human embryonic stem cell lines derived from single blastomeres of two 4-cell stage embryos. Hum Reprod 2009;24:2709-2717.
18. Halford S, Sasieni P, Rowan A, Halford S, Sasieni P, Rowan A, Wasan H, Bodmer W, Talbot I, Hawkins N et al. Low-level microsatellite instability occurs in most colorectal cancers and is a nonrandomly distributed quantitative trait advances in brief low-level microsatellite instability occurs in most colorectal cancers and is a nonrandomly distributed quantitative trait. Cancer Res 2002;53-57.
19. Hudler P. Genetic aspects of gastric cancer instability. Sci World J 2012; 2012:761909.
20. Imai K, Yamamoto H. Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics. Carcinogenesis 2008; 29:673-680.
21. Jacobs K, Mertzanidou A, Geens M, Nguyen HT, Staessen C, Spits C. Nat Commun 2014;5:4227.
22. Jiricny J. The multifaceted mismatch-repair system. Nat Rev Mol Cell Biol 2006; 7:335-346.
23. Josephson R, Sykes G, Liu Y, Ording C, Xu W, Zeng X, Shin S, Loring J, Maitra A, Rao MS et al. A molecular scheme for improved characterization of human embryonic stem cell lines. BMC Biology 2006; 4:28.
24. Lund RJ, Närvä E, Lahesmaa R. Genetic and epigenetic stability of human pluripotent stem cells. Nat Rev Genet 2012;13:732-744.
25. Mateizel I, De Temmerman N, Ullmann U, Cauffman G, Sermon K, Van de Velde H, De Rycke M, Degreef E, Devroey P, Liebaers I et al. Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders. Hum Reprod 2006;21: 503-511.
26. Mateizel I, Spits C, Rycke M, Liebaers I, Sermon K. Derivation, culture, and characterization of VUB hESC lines. In Vitro Cell Dev Biol Anim 2010; 46:300-308.
27. Mfopou JK, Chen B, Mateizel I, Sermon K, Bouwens L. Noggin, retinoids, and fibroblast growth factor regulate hepatic or pancreatic fate of human embryonic stem cells. Gastroenterology 2010;138:2233-2245, e1-14.
28. Mori Y, Yin J, Rashid A, Leggett BA, Young J, Simms L, Kuehl PM, Langenberg P, Meltzer SJ, Stine OC. Instabilotyping: comprehensive identification of frameshift mutations caused by coding region microsatellite instability. Cancer Res 2001;61:6046-6049.
29. Na J, Baker D, Zhang J, Andrews PW, Barbaric I. Aneuploidy in pluripotent stem cells and implications for cancerous transformation. Protein Cell 2014. doi:10.1007/s13238-014-0073-9.
30. Nguyen HT, Geens M, Spits C. Genetic and epigenetic instability in human pluripotent stem cells. Hum Reprod Update 2012;19:187-205.
31. Nguyen HT, Geens M, Mertzanidou A, Jacobs K, Heirman C, Breckpot K, Spits C. Gain of 20q11.21 in human embryonic stem cells improves cell survival by increased expression of Bcl-x L. Mol Hum Reprod 2014; 20:168-177.
32. Niini T, Lahti L, Michelacci F, Ninomiya S, Hattinger CM, Guled M, Bohling T, Picci P, Serra M, Knuutila S. Array comparative genomic hybridization reveals frequent alterations of G1/S checkpoint genes in undifferentiated pleomorphic sarcoma of bone. Genes Chromosomes Cancer 2011; 50:291-306.
33. Parsons R, Myeroff LL, Liu B, Wilison JKV, Markowitz SD, Kinzler KW, Vogelstein B. Microsatellite instability and mutations of the transforming growth factor b type II receptor gene in colorectal cancer type II receptor gene in colorectal cancer. Cancer Res 1995;55:5548-5550.
34. Passier R. Potential of human embryonic stem cells in regenerative medicine. Horm Res 2003;60:11-14.
35. Peterson SE, Westra JW, Rehen SK, Young H, Bushman DM, Paczkowski CM, Yung YC, Lynch CL, Tran HT, Nickey KS et al. Normal human pluripotent stem cell lines exhibit pervasive mosaic aneuploidy. PLoS One 2011;6:e23018.
36. Rampino N. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 1997;275:967-969.
37. Spits C, Mateizel I, Geens M, Mertzanidou A, Staessen C,Vandeskelde Y, Van der Elst J, Liebaers I, Sermon K. Recurrent chromosomal abnormalities in human embryonic stem cells. Nat Biotechnol 2008;26:1361-1363.
38. Tabach Y, Kogan-Sakin I, Buganim Y, Solomon H, Goldfinger N, Hovland R, Ke X-S, Oyan AM, Kalland K-H, Rotter V et al. Amplification of the 20q chromosomal arm occurs early in tumorigenic transformation and may initiate cancer. PloS One 2011;6:e14632.
39. The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012; 487:330-337.
40. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993;260:816-819.
41. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel J, Marshall VS, Jones JM. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-1147.
42. Tuya Pal MD, Jenny Permuth-Wey MS, Thomas A, Sellers M. A review of the clinical relevance of mismatch-repair deficiency in ovarian cancer. Cancer 2008;113:733-742.
43. Van Haute L, Spits C, Geens M, Seneca S, Sermon K. Human embryonic stem cells commonly display large mitochondrial DNA deletions. Nat Biotechnol 2013;31:20-23.
44. Weber JL. Informativeness of human (dC-dA)n.(dG-dT)n polymorphisms. Genomics 1990;7:524-530.
45. Werbowetski-Ogilvie TE, Bossé M, Stewart M, Schnerch A, Ramos-Mejia V, Rouleau A, Wynder T, Smith M-J, Dingwall S, Carter T et al. Characterization of human embryonic stem cells with features of neoplastic progression. Nat Biotechnol 2009;27:91-97.
46. Xie T, Ario G, Lamb JR, Martin E,Wang K, Tejpar S, Delorenzi M, Bosman FT, Roth AD, Yan P et al. A comprehensive characterization of genome-wide copy number aberrations in colorectal cancer reveals novel oncogenes and patterns of alterations. Plo S One 2012;7:e42001.
47. Yang S, Lin G, Tan Y-Qiu, Zhou D, Deng L-Yu, Cheng D-Hua, Luo S-Wei, Liu T-Cheng, Zhou X-Ying, Sun Z et al. Tumor progression of cultureadapted human embryonic stem cells during long-term culture. Genes Chromosomes Cancer 2008;47:665-679.